Zhu M et al., 2017-10: Renal cell carcinoma study reporting that ivermectin preferentially kills RCC cells over normal kidney cells by collapsing mitochondrial membrane potential, respiration and ATP production, with oxidative damage in vitro and in xenografts, effects reversed by ALCAR or NAC.
Mechanistically, ivermectin induces mitochondrial dysfunction via decreasing mitochondrial membrane potential, mitochondrial respiration and ATP production.
n/a (PubMed abstract)
Zhu M et al., 2017-10: Renal cell carcinoma study reporting that ivermectin preferentially kills RCC cells over normal kidney cells by collapsing mitochondrial membrane potential, respiration and ATP production, with oxidative damage in vitro and in xenografts, effects reversed by ALCAR or NAC. Study type: RCC cell lines + mouse xenograft. N: not stated in the abstract. Country: China (Jingzhou Central Hospital, Yangtze University). Dose: not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: normal kidney cells, and rescue with acetyl-L-carnitine or N-acetylcysteine, which identifies mitochondria as the target. This is the 'Zhu M et al.' lead named in the prompt, confirmed. Study type: animal.
